{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:48:29Z","timestamp":1792648109715,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,9,19]],"date-time":"2017-09-19T00:00:00Z","timestamp":1505779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cachexia, characterized by muscle wasting, is a major contributor to cancer-related mortality. However, the key cachexins that mediate cancer-induced muscle wasting remain elusive. Here, we show that tumor-released extracellular Hsp70 and Hsp90 are responsible for tumor\u2019s capacity to induce muscle wasting. We detected high-level constitutive release of Hsp70 and Hsp90 associated with extracellular vesicles (EVs) from diverse cachexia-inducing tumor cells, resulting in elevated serum levels in mice. Neutralizing extracellular Hsp70\/90 or silencing Hsp70\/90 expression in tumor cells abrogates tumor-induced muscle catabolism and wasting in cultured myotubes and in mice. Conversely, administration of recombinant Hsp70 and Hsp90 recapitulates the catabolic effects of tumor. In addition, tumor-released Hsp70\/90-expressing EVs are necessary and sufficient for tumor-induced muscle wasting. Further, Hsp70 and Hsp90 induce muscle catabolism by activating TLR4, and are responsible for elevation of circulating cytokines. These findings identify tumor-released circulating Hsp70 and Hsp90 as key cachexins causing muscle wasting in mice.<\/jats:p>","DOI":"10.1038\/s41467-017-00726-x","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T06:56:45Z","timestamp":1505285805000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":220,"title":["Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90"],"prefix":"10.1038","volume":"8","author":[{"given":"Guohua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhelong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Anh","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Wai Thomas","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren J.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2121-7538","authenticated-orcid":false,"given":"Yefei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0811-2790","authenticated-orcid":false,"given":"Yi-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,19]]},"reference":[{"key":"726_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"726_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","volume":"16","author":"KC Fearon","year":"2012","unstructured":"Fearon, K. C., Glass, D. J. & Guttridge, D. C. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab. 16, 153\u2013166 (2012).","journal-title":"Cell Metab."},{"key":"726_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0959-8049(97)10090-9","volume":"34","author":"HJ Andreyev","year":"1998","unstructured":"Andreyev, H. J., Norman, A. R., Oates, J. & Cunningham, D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur. J. Cancer 34, 503\u2013509 (1998).","journal-title":"Eur. J. Cancer"},{"key":"726_CR4","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1038\/emboj.2011.292","volume":"30","author":"G Zhang","year":"2011","unstructured":"Zhang, G., Jin, B. & Li, Y. P. C\/EBPbeta mediates tumour-induced ubiquitin ligase atrogin1\/MAFbx upregulation and muscle wasting. EMBO J. 30, 4323\u20134335 (2011).","journal-title":"EMBO J."},{"key":"726_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-20","volume":"2","author":"G Zhang","year":"2012","unstructured":"Zhang, G. & Li, Y. P. p38beta MAPK upregulates atrogin1\/MAFbx by specific phosphorylation of C\/EBPbeta. Skeletal Muscle 2, 20 (2012).","journal-title":"Skeletal Muscle"},{"key":"726_CR6","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1002\/ijc.25146","volume":"127","author":"F Penna","year":"2010","unstructured":"Penna, F. et al. Muscle atrophy in experimental cancer cachexia: is the IGF-1 signaling pathway involved? Int. J. Cancer 127, 1706\u20131717 (2010).","journal-title":"Int. J. Cancer"},{"key":"726_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.3945\/ajcn.113.058388","volume":"98","author":"CM Op den Kamp","year":"2013","unstructured":"Op den Kamp, C. M. et al. Nuclear transcription factor kappa B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am. J. Clin. Nutr. 98, 738\u2013748 (2013).","journal-title":"Am. J. Clin. Nutr."},{"key":"726_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/jcsm.12005","volume":"6","author":"NA Stephens","year":"2015","unstructured":"Stephens, N. A. et al. Evaluating potential biomarkers of cachexia and survival in skeletal muscle of upper gastrointestinal cancer patients. J. Cachexia Sarcopenia Muscle 6, 53\u201361 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"726_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00424-008-0574-6","volume":"457","author":"KA Baltgalvis","year":"2009","unstructured":"Baltgalvis, K. A. et al. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc (Min\/+) mouse. Pflugers Arch. 457, 989\u20131001 (2009).","journal-title":"Pflugers Arch."},{"key":"726_CR10","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1096\/fj.12-222711","volume":"27","author":"G Zhang","year":"2013","unstructured":"Zhang, G., Lin, R. K., Kwon, Y. T. & Li, Y. P. Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2. FASEB J. 27, 2893\u20132901 (2013).","journal-title":"FASEB J."},{"key":"726_CR11","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1517\/13543784.2014.942729","volume":"23","author":"AM Dingemans","year":"2014","unstructured":"Dingemans, A. M., de Vos-Geelen, J., Langen, R. & Schols, A. M. Phase II drugs that are currently in development for the treatment of cachexia. Expert Opin. Investig. Drugs 23, 1655\u20131669 (2014).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"726_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1207\/S15327914NC352_5","volume":"35","author":"P O\u2019Gorman","year":"1999","unstructured":"O\u2019Gorman, P., McMillan, D. C. & McArdle, C. S. Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr. Cancer 35, 127\u2013129 (1999).","journal-title":"Nutr. Cancer"},{"key":"726_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0149-2918(05)80001-3","volume":"69","author":"WD Dewys","year":"1980","unstructured":"Dewys, W. D. et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am. J. Med. 69, 491\u2013497 (1980).","journal-title":"Am. J. Med."},{"key":"726_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s002620050326","volume":"43","author":"C Botzler","year":"1996","unstructured":"Botzler, C., Issels, R. & Multhoff, G. Heat-shock protein 72 cell-surface expression on human lung carcinoma cells in associated with an increased sensitivity to lysis mediated by adherent natural killer cells. Cancer Immunol. Immunother. 43, 226\u2013230 (1996).","journal-title":"Cancer Immunol. Immunother."},{"key":"726_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<942::AID-IJC25>3.0.CO;2-1","volume":"77","author":"C Botzler","year":"1998","unstructured":"Botzler, C. et al. Differential Hsp70 plasma-membrane expression on primary human tumors and metastases in mice with severe combined immunodeficiency. Int. J. Cancer 77, 942\u2013948 (1998).","journal-title":"Int. J. Cancer"},{"key":"726_CR16","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.4049\/jimmunol.158.9.4341","volume":"158","author":"G Multhoff","year":"1997","unstructured":"Multhoff, G. et al. Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. J. Immunol. 158, 4341\u20134350 (1997).","journal-title":"J. Immunol."},{"key":"726_CR17","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ijc.2910510418","volume":"51","author":"M Ferrarini","year":"1992","unstructured":"Ferrarini, M., Heltai, S., Zocchi, M. R. & Rugarli, C. Unusual expression and localization of heat-shock proteins in human tumor cells. Int. J. Cancer 51, 613\u2013619 (1992).","journal-title":"Int. J. Cancer"},{"key":"726_CR18","doi-asserted-by":"publisher","first-page":"15874","DOI":"10.1074\/jbc.M112.340588","volume":"287","author":"LH Lv","year":"2012","unstructured":"Lv, L. H. et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J. Biol. Chem. 287, 15874\u201315885 (2012).","journal-title":"J. Biol. Chem."},{"key":"726_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-10-294","volume":"10","author":"J McCready","year":"2010","unstructured":"McCready, J., Sims, J. D., Chan, D. & Jay, D. G. Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10, 294 (2010).","journal-title":"BMC Cancer"},{"key":"726_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0269-y","volume":"9","author":"X Li","year":"2016","unstructured":"Li, X. et al. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFkappaB-TLR signaling pathway. J. Hematol. Oncol. 9, 42 (2016).","journal-title":"J. Hematol. Oncol."},{"key":"726_CR21","first-page":"457","volume":"120","author":"F Chalmin","year":"2010","unstructured":"Chalmin, F. et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J. Clin. Invest. 120, 457\u2013471 (2010).","journal-title":"J. Clin. Invest."},{"key":"726_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0306164","volume":"81","author":"ME Bianchi","year":"2007","unstructured":"Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1\u20135 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"726_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1021\/bi00429a001","volume":"28","author":"LM Gierasch","year":"1989","unstructured":"Gierasch, L. M. Signal sequences. Biochemistry 28, 923\u2013930 (1989).","journal-title":"Biochemistry"},{"key":"726_CR24","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v3.26913","volume":"3","author":"J Lotvall","year":"2014","unstructured":"Lotvall, J. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J. Extracell. Vesicles 3, 26913 (2014).","journal-title":"J. Extracell. Vesicles"},{"key":"726_CR25","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.3892\/or.2016.5066","volume":"36","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto, Y. et al. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol. Rep. 36, 2535\u20132543 (2016).","journal-title":"Oncol. Rep."},{"key":"726_CR26","doi-asserted-by":"publisher","first-page":"5238","DOI":"10.1158\/0008-5472.CAN-04-3804","volume":"65","author":"R Gastpar","year":"2005","unstructured":"Gastpar, R. et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65, 5238\u20135247 (2005).","journal-title":"Cancer Res."},{"key":"726_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ncb2000","volume":"12","author":"M Ostrowski","year":"2010","unstructured":"Ostrowski, M. et al. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat. Cell Biol. 12, 19\u201330 (2010).","journal-title":"Nat. Cell Biol."},{"key":"726_CR28","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.2174\/156652412803306710","volume":"12","author":"Y Tamura","year":"2012","unstructured":"Tamura, Y., Torigoe, T., Kutomi, G., Hirata, K. & Sato, N. New paradigm for intrinsic function of heat shock proteins as endogenous ligands in inflammation and innate immunity. Curr. Mol. Med. 12, 1198\u20131206 (2012).","journal-title":"Curr. Mol. Med."},{"key":"726_CR29","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.shk.0000055237.25446.80","volume":"19","author":"CH Lang","year":"2003","unstructured":"Lang, C. H., Silvis, C., Deshpande, N., Nystrom, G. & Frost, R. A. Endotoxin stimulates in vivo expression of inflammatory cytokines tumor necrosis factor alpha, interleukin-1beta, -6, and high-mobility-group protein-1 in skeletal muscle. Shock 19, 538\u2013546 (2003).","journal-title":"Shock"},{"key":"726_CR30","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1128\/IAI.00286-06","volume":"74","author":"JH Boyd","year":"2006","unstructured":"Boyd, J. H. et al. Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin. Infect. Immun. 74, 6829\u20136838 (2006).","journal-title":"Infect. Immun."},{"key":"726_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/intimm\/dxh186","volume":"17","author":"K Takeda","year":"2005","unstructured":"Takeda, K. & Akira, S. Toll-like receptors in innate immunity. Int. Immunol. 17, 1\u201314 (2005).","journal-title":"Int. Immunol."},{"key":"726_CR32","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","volume":"513","author":"S Kir","year":"2014","unstructured":"Kir, S. et al. Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature 513, 100\u2013104 (2014).","journal-title":"Nature"},{"key":"726_CR33","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1016\/j.bbapap.2013.04.005","volume":"1834","author":"JM Inal","year":"2013","unstructured":"Inal, J. M. et al. Blood\/plasma secretome and microvesicles. Biochim. Biophys. Acta 1834, 2317\u20132325 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"726_CR34","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/gutjnl-2014-308350","volume":"65","author":"G Sagar","year":"2016","unstructured":"Sagar, G. et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut 65, 1165\u20131174 (2016).","journal-title":"Gut"},{"key":"726_CR35","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.2174\/092986711797189574","volume":"18","author":"RE Wang","year":"2011","unstructured":"Wang, R. E. Targeting heat shock proteins 70\/90 and proteasome for cancer therapy. Curr. Med. Chem. 18, 4250\u20134264 (2011).","journal-title":"Curr. Med. Chem."},{"key":"726_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1096\/fj.03-0395fje","volume":"18","author":"A McArdle","year":"2004","unstructured":"McArdle, A., Dillmann, W. H., Mestril, R., Faulkner, J. A. & Jackson, M. J. Overexpression of HSP70 in mouse skeletal muscle protects against muscle damage and age-related muscle dysfunction. FASEB J. 18, 355\u2013357 (2004).","journal-title":"FASEB J."},{"key":"726_CR37","doi-asserted-by":"publisher","first-page":"3836","DOI":"10.1096\/fj.08-110163","volume":"22","author":"SM Senf","year":"2008","unstructured":"Senf, S. M., Dodd, S. L., McClung, J. M. & Judge, A. R. Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J. 22, 3836\u20133845 (2008).","journal-title":"FASEB J."},{"key":"726_CR38","doi-asserted-by":"publisher","first-page":"C38","DOI":"10.1152\/ajpcell.00315.2009","volume":"298","author":"SM Senf","year":"2010","unstructured":"Senf, S. M., Dodd, S. L. & Judge, A. R. FOXO signaling is required for disuse muscle atrophy and is directly regulated by Hsp70. Am. J. Physiol. Cell Physiol. 298, C38\u2013C45 (2010).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"726_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02347-2","volume":"7","author":"G Zhang","year":"2017","unstructured":"Zhang, G. et al. Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways. Sci. Rep. 7, 2273 (2017).","journal-title":"Sci. Rep."},{"key":"726_CR40","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1001\/archotol.133.12.1263","volume":"133","author":"TY Cannon","year":"2007","unstructured":"Cannon, T. Y. et al. The effect of altered Toll-like receptor 4 signaling on cancer cachexia. Arch. Otolaryngol. Head Neck Surg. 133, 1263\u20131269 (2007).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"726_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1096\/fj.10-164152","volume":"25","author":"A Doyle","year":"2011","unstructured":"Doyle, A., Zhang, G., Abdel Fattah, E. A., Eissa, N. T. & Li, Y. P. Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways. FASEB J. 25, 99\u2013110 (2011).","journal-title":"FASEB J."},{"key":"726_CR42","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1158\/1055-9965.EPI-06-0005","volume":"15","author":"K Suzuki","year":"2006","unstructured":"Suzuki, K. et al. Serum heat shock protein 70 levels and lung cancer risk: a case-control study nested in a large cohort study. Cancer Epidemiol. Biomarkers Prev. 15, 1733\u20131737 (2006).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"726_CR43","doi-asserted-by":"publisher","first-page":"6016","DOI":"10.1158\/1078-0432.CCR-14-0174","volume":"20","author":"Y Shi","year":"2014","unstructured":"Shi, Y. et al. Plasma levels of heat shock protein 90 alpha associated with lung cancer development and treatment responses. Clin. Cancer Res. 20, 6016\u20136022 (2014).","journal-title":"Clin. Cancer Res."},{"key":"726_CR44","first-page":"874","volume":"4","author":"B Rong","year":"2014","unstructured":"Rong, B. et al. Identification and verification of Hsp90-beta as a potential serum biomarker for lung cancer. Am. J. Cancer Res. 4, 874\u2013885 (2014).","journal-title":"Am. J. Cancer Res."},{"key":"726_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00556","volume":"6","author":"S Gunther","year":"2015","unstructured":"Gunther, S. et al. Correlation of Hsp70 serum levels with gross tumor volume and composition of lymphocyte subpopulations in patients with squamous cell and adeno non-small cell lung cancer. Front. Immunol. 6, 556 (2015).","journal-title":"Front. Immunol."},{"key":"726_CR46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12253-016-0118-x","volume":"23","author":"M Balazs","year":"2016","unstructured":"Balazs, M. et al. Serum heat shock protein 70, as a potential biomarker for small cell lung cancer. Pathol. Oncol. Res. 23, 377\u2013383 (2016).","journal-title":"Pathol. Oncol. Res."},{"key":"726_CR47","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12192-016-0758-5","volume":"22","author":"B Ren","year":"2017","unstructured":"Ren, B. et al. The expression of DAMP proteins HSP70 and cancer-testis antigen SPAG9 in peripheral blood of patients with HCC and lung cancer. Cell Stress Chaperones 22, 237\u2013244 (2017).","journal-title":"Cell Stress Chaperones"},{"key":"726_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12192-009-0128-7","volume":"15","author":"J Kocsis","year":"2010","unstructured":"Kocsis, J., Madaras, B., Toth, E. K., Fust, G. & Prohaszka, Z. Serum level of soluble 70-kD heat shock protein is associated with high mortality in patients with colorectal cancer without distant metastasis. Cell Stress Chaperones 15, 143\u2013151 (2010).","journal-title":"Cell Stress Chaperones"},{"key":"726_CR49","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/MPA.0b013e3182374ace","volume":"41","author":"SK Dutta","year":"2012","unstructured":"Dutta, S. K. et al. Serum HSP70: a novel biomarker for early detection of pancreatic cancer. Pancreas 41, 530\u2013534 (2012).","journal-title":"Pancreas"},{"key":"726_CR50","first-page":"669","volume":"25","author":"F Zagouri","year":"2011","unstructured":"Zagouri, F. et al. Serum levels of HSP90 in the continuum of breast ductal and lobular lesions. In Vivo 25, 669\u2013672 (2011).","journal-title":"In Vivo"},{"key":"726_CR51","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/gcc.21926","volume":"51","author":"J Silva","year":"2012","unstructured":"Silva, J. et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 51, 409\u2013418 (2012).","journal-title":"Genes Chromosomes Cancer"},{"key":"726_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0372-2","volume":"32","author":"Q Wang","year":"2015","unstructured":"Wang, Q. et al. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival. Med. Oncol. 32, 372 (2015).","journal-title":"Med. Oncol."},{"key":"726_CR53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3816\/CLC.2009.n.006","volume":"10","author":"G Rabinowits","year":"2009","unstructured":"Rabinowits, G., Gercel-Taylor, C., Day, J. M., Taylor, D. D. & Kloecker, G. H. Exosomal microRNA: a diagnostic marker for lung cancer. Clin. Lung Cancer 10, 42\u201346 (2009).","journal-title":"Clin. Lung Cancer"},{"key":"726_CR54","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/ncb1131","volume":"6","author":"BK Eustace","year":"2004","unstructured":"Eustace, B. K. et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 6, 507\u2013514 (2004).","journal-title":"Nat. Cell Biol."},{"key":"726_CR55","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.4049\/jimmunol.162.7.3749","volume":"162","author":"K Hoshino","year":"1999","unstructured":"Hoshino, K. et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162, 3749\u20133752 (1999).","journal-title":"J. Immunol."},{"key":"726_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-1-61779-068-3_15","volume":"728","author":"DD Taylor","year":"2011","unstructured":"Taylor, D. D., Zacharias, W. & Gercel-Taylor, C. Exosome isolation for proteomic analyses and RNA profiling. Methods Mol. Biol. 728, 235\u2013246 (2011).","journal-title":"Methods Mol. Biol."},{"key":"726_CR57","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1152\/japplphysiol.00975.2004","volume":"98","author":"KA Mehl","year":"2005","unstructured":"Mehl, K. A. et al. Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin\/+ mice. J. Appl. Physiol. 98, 2219\u20132225 (2005).","journal-title":"J. Appl. Physiol."},{"key":"726_CR58","first-page":"733","volume":"50","author":"TP Waalkes","year":"1957","unstructured":"Waalkes, T. P. & Udenfriend, S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 50, 733\u2013736 (1957).","journal-title":"J. Lab. Clin. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00726-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00726-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00726-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T15:56:48Z","timestamp":1692979008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00726-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,19]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["726"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-00726-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,19]]},"assertion":[{"value":"16 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"589"}}